Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era.

PubWeight™: 2.46‹?› | Rank: Top 2%

🔗 View Article (PMID 4152800)

Published in Arch Intern Med on September 01, 1974

Authors

M A Mufson, D M Kruss, R E Wasil, W I Metzger

Articles citing this

Pneumococcal resistance to antibiotics. Clin Microbiol Rev (1990) 9.76

Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J Clin Microbiol (1977) 3.37

Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis (2010) 2.50

Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun (1975) 2.32

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med (2009) 2.13

Counterimmunoelectrophoresis of pneumococcal antigens:improved sensitivity for the detection of types VII and XIV. J Clin Microbiol (1975) 1.94

Phenotypic characterization of Streptococcus pneumoniae biofilm development. J Bacteriol (2006) 1.93

Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect Immun (1977) 1.92

Role of gamma interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect Immun (1997) 1.60

Identification of hydrogen peroxide as a Streptococcus pneumoniae toxin for rat alveolar epithelial cells. Infect Immun (1993) 1.60

Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis (2004) 1.52

Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect Immun (1992) 1.51

Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics. J Clin Microbiol (1989) 1.48

Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status. Public Health Rep (1989) 1.46

Toxicity of pneumolysin to pulmonary alveolar epithelial cells. Infect Immun (1993) 1.45

Periodic health examination, 1991 update: 2. Administration of pneumococcal vaccine. Canadian Task Force on the Periodic Health Examination. CMAJ (1991) 1.25

Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis (2011) 1.19

Pneumolysin activates phospholipase A in pulmonary artery endothelial cells. Infect Immun (1994) 1.13

Important infections in elderly persons. West J Med (1981) 1.05

Serotypes and penicillin susceptibility of pneumococci isolated from blood. J Clin Microbiol (1980) 1.05

The syndrome of pneumococcemia, disseminated intravascular coagulation and asplenia. Can Med Assoc J (1979) 1.04

Nasopharyngeal carriage of community-acquired, antibiotic-resistant Streptococcus pneumoniae in a Zambian paediatric population. Bull World Health Organ (1997) 1.03

Characterization of the murine immune response to type 6 pneumococcal polysaccharide. Infect Immun (1983) 1.03

Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. PLoS One (2009) 0.96

Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates. J Clin Microbiol (2000) 0.96

Fatal infection caused by a multiply resistant type 3 pneumococcus. J Clin Microbiol (1988) 0.94

Pneumococcal serotypes causing bacteremia and meningitis: relevance to composition of pneumococcal vaccine. Can Med Assoc J (1981) 0.91

Death rates among patients hospitalized with community-acquired pneumonia: a reexamination with data from three states. Am J Public Health (1996) 0.89

Isolation and characterization of circulating immune complexes from patients with pneumococcal pneumonia. Infect Immun (1987) 0.88

Serotype-specific effect of influenza on adult invasive pneumococcal pneumonia. J Infect Dis (2013) 0.86

Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia. Antimicrob Agents Chemother (2002) 0.85

Serogroups and serotypes of pneumococci in Montreal: correlations with age, outcome and indications for vaccination. Can Med Assoc J (1984) 0.83

Risk factors for septicemia-associated mortality in older adults. Public Health Rep (1993) 0.83

Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide. J Clin Microbiol (1991) 0.83

Population biology of Streptococcus pneumoniae in West Africa: multilocus sequence typing of serotypes that exhibit different predisposition to invasive disease and carriage. PLoS One (2013) 0.82

Pneumococcal pneumonia: differences according to blood culture results. BMC Pulm Med (2014) 0.76

Radioimmunoassay and opsonic antibody responses to pneumococcal capsular polysaccharide vaccine in serum and ascitic fluid of cirrhotic patients. J Clin Microbiol (1983) 0.76

Relationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection. J Clin Microbiol (1986) 0.76

Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia. Antimicrob Agents Chemother (2006) 0.76

Pneumococcal intracellular killing is abolished by polysaccharide despite serum complement activity. Infect Immun (1986) 0.75

Infectious diseases: fortieth and final annual review of significant publications. Postgrad Med J (1975) 0.75

S. pneumoniae: important contributor to morbidity and mortality in patients with chronic obstructive pulmonary disease--fact or fiction? Trans Am Clin Climatol Assoc (1987) 0.75

Articles by these authors

A new plating medium for the isolation of enteric pathogens. I. hektoen enteric agar. Appl Microbiol (1968) 7.04

Two distinct subtypes of human respiratory syncytial virus. J Gen Virol (1985) 5.19

Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis (1974) 2.55

Deaths in bacteremic pneumococcal pneumonia. A comparison of two populations--Huntington, WVa, and Stockholm, Sweden. Chest (1993) 2.17

Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J Infect Dis (1982) 2.17

United we stand. Ann Intern Med (1993) 2.16

Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses. J Virol (1991) 2.14

A new plating medium for the isolation of enteric pathogens. II. Comparison of hektoen enteric agar with SS and EMB agar. Appl Microbiol (1968) 2.14

The role of viruses, mycoplasmas and bacteria in acute pneumonia in civilian adults. Am J Epidemiol (1967) 2.11

Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol (1987) 2.06

Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus. J Infect Dis (1976) 1.95

Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. Clin Infect Dis (1993) 1.78

Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. J Gen Virol (1987) 1.73

Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus. Proc Natl Acad Sci U S A (1987) 1.55

Structural differences between subtype A and B strains of respiratory syncytial virus. J Gen Virol (1986) 1.45

Safety of cimetidine. Gastroenterology (1978) 1.34

Penicillin in infants weighing two kilograms or less with early-onset Group B streptococcal disease. N Engl J Med (1983) 1.31

Cimetidine, antacid, and hospitalization in the treatment of benign gastric ulcer: a multicenter double blind study. Gastroenterology (1978) 1.30

Pneumococcal infections. JAMA (1981) 1.30

Spontaneous bacterial peritonitis due to a group IIk-2 strain. J Clin Microbiol (1980) 1.30

Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis (2000) 1.29

Diplococcus pneumoniae infections in children with sickle cell anemia. Am J Dis Child (1972) 1.29

Viral antibodies among the Turkana people of Northern Kenya. Trop Geogr Med (1972) 1.27

Respiratory syncytial virus: heterogeneity of subgroup B strains. J Gen Virol (1988) 1.27

Simultaneous nosocomial and community outbreak of epidemic keratoconjunctivitis with types 8 and 19 adenovirus. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol (1977) 1.25

Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis (2000) 1.23

Pneumococcal disease in a medium-sized community in the United States. JAMA (1982) 1.22

Evaluation of therapeutic options for pancreatic pseudocysts. Arch Surg (1982) 1.16

Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children. J Infect Dis (1998) 1.14

Pneumococcal bacteremia in infants and children: a ten-year experience at the Cook County Hospital with special reference to the pneumococcal serotypes isolated. Pediatrics (1979) 1.08

Epidemiology of respiratory syncytial virus infection among infants and children in Chicago. Am J Epidemiol (1973) 1.05

Viruses, Mycoplasma pneumoniae and bacteria associated with lower respiratory tract disease among infants. Am J Epidemiol (1970) 1.03

Acquisition of parainfluenza 3 virus infection by hospitalized children. I. Frequencies, rates, and temporal data. J Infect Dis (1973) 1.00

Pneumococcal vaccine after 15 years of use. Another view. Arch Intern Med (1994) 1.00

Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis (1978) 0.99

A subgroup-specific antigenic site in the G protein of respiratory syncytial virus forms a disulfide-bonded loop. J Virol (1990) 0.99

Epidemiology of severe respiratory syncytial virus infections in Huntington, West Virginia. W V Med J (1981) 0.98

Shedding of infectious virus and virus antigen during acute infection with respiratory syncytial virus. J Med Virol (1992) 0.98

The sudden infant death syndrome and epidemic viral disease. Am J Epidemiol (1975) 0.97

Impact of viral respiratory diseases on infants and young children in a rural and urban area of southern West Virginia. Am J Epidemiol (1983) 0.97

Long-term persistence of antibody following immunization with pneumococcal polysaccharide vaccine. Proc Soc Exp Biol Med (1983) 0.97

Intraluminal fungal colonization of gastrostomy tubes. Gastrointest Endosc (1993) 0.97

Mycoplasma hominis: a review of its role as a respiratory tract pathogen of humans. Sex Transm Dis (1984) 0.93

Pneumococcal antibody levels one decade after immunization of healthy adults. Am J Med Sci (1987) 0.93

A 20-year epidemiological study of pneumococcal meningitis. Clin Infect Dis (1999) 0.92

Comparative biology and ecology of human virus and Mycoplasma respiratory pathogens. Prog Med Virol (1965) 0.89

A review of adenoviruses in the etiology of acute hemorrhagic cystitis. J Urol (1976) 0.88

Characterization of two newly recognized rhinovirus serotypes of human origin. Proc Soc Exp Biol Med (1966) 0.88

Adenovirus infection in acute hemorrhagic cystitis. A study in 25 children. Am J Dis Child (1971) 0.88

Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis (2006) 0.88

Cause of acute hemorrhagic cystitis in children. Am J Dis Child (1973) 0.87

Clinical aspects and importance of pneumococcal infections. Pathol Biol (Paris) (1979) 0.86

Comparison of enzyme-linked immunosorbent assay and neutralization techniques for measurement of antibody to respiratory syncytial virus: implications for parenteral immunization with live virus vaccine. Infect Immun (1982) 0.86

Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1. Dig Dis Sci (1985) 0.85

Emergence of penicillin-resistant invasive pneumococci in a single American community. Am J Med Sci (1995) 0.84

Occurrence, characteristics, and patterns of HIV-1 and HIV-2 western blot indeterminate sera in low risk populations in West Virginia and pre-AIDS Africa. Am J Trop Med Hyg (1990) 0.84

Distinguishing between respiratory syncytial virus subgroups by protein profile analysis. J Clin Microbiol (1992) 0.83

Identification by immunofluorescence of adenoviral antigen in exfoliated bladder epithelial cells from patients with acute hemorrhagic cystitis. Proc Soc Exp Biol Med (1974) 0.82

common duct obstruction in patients with intractable pain of chronic pancreatitis. Am Surg (1982) 0.82

Professionalism in medicine: the department chair's perspective on medical students and residents. Am J Med (1997) 0.82

The treatment of pyogenic bone and joint infections by closed irrigation (circulation) with a non-toxic detergent and one or more antibiotics. J Bone Joint Surg Am (1967) 0.82

Myocarditis and pneumonitis with type 21 adenovirus infection. Association with fatal myocarditis and pneumonitis. Am J Dis Child (1971) 0.81

The immunobiology of respiratory syncytial virus: prospects for a vaccine. Adv Exp Med Biol (1989) 0.81

Relationship of rehinovirus infection to mild upper respiratory disease. 3. Further epidemiologic observations in military personnel. Am J Epidemiol (1966) 0.80

Penicillin-resistant Streptococcus pneumoniae increasingly threatens the patient and challenges the physician. Clin Infect Dis (1998) 0.80

Viral antibodies in the Korekore Tribe of Northern Rhodesia. Trop Geogr Med (1971) 0.80

Mycoplasma hominis I in respiratory tract infections. Ann N Y Acad Sci (1970) 0.79

Surveillance of penicillin-resistant Streptococcus pneumoniae in one American metropolitan area, 1989-1998. Eur J Clin Microbiol Infect Dis (2000) 0.79

Identification of subgroups of bovine respiratory syncytial virus. J Clin Microbiol (1992) 0.79

Type-specific antibody responses of volunteers immunized with 23-valent pneumococcal polysaccharide vaccine. J Infect Dis (1985) 0.79

Apnea and cardiopulmonary arrest during and after endoscopy. J Clin Gastroenterol (1992) 0.78

Pathogenicity of Coxsackie A-21 virus for suckling mice. Proc Soc Exp Biol Med (1968) 0.78

Evaluation of subgroup-specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response. J Med Virol (1995) 0.78

Etiology of upper-respiratory-tract illnesses among civilian adults. JAMA (1966) 0.78

Antibodies to viruses of human origin in monkeys from Uganda. Proc Soc Exp Biol Med (1974) 0.78

Viral and mycoplasmal infections in minor respiratory illnesses and nonstreptococcal pharyngitis. A search for coronaviruses using fetal trachea organ cultures. Am Rev Respir Dis (1971) 0.78

Microbiologic studies on young infants with lower respiratory tract disease. Am J Dis Child (1973) 0.78

The case against "the case against the catheter": initial report. J Urol (1969) 0.77

Nonbacterial respiratory infections. Dis Mon (1975) 0.76

Acute parotitis associated with parainfluenza 3 virus infection. Am J Dis Child (1970) 0.76

Antibody responses of children to the C-terminal peptide of the SH protein of respiratory syncytial virus and the immunological characterization of this protein. J Med Virol (1993) 0.76

Reactivity and antibody responses of volunteers given two or three doses of pneumococcal vaccine. Proc Soc Exp Biol Med (1984) 0.75

Sterility of the aqueous humor following cataract surgery. Am J Ophthalmol (1972) 0.75

Modern diagnostic methods of viral infections and their treatment. Kansenshogaku Zasshi (1988) 0.75

Viral antibodies in the Mano tribe of Northern Liberia. Trop Geogr Med (1972) 0.75

Detection of antigen in immune precipitates by silver staining of SDS-polyacrylamide gels. J Virol Methods (1986) 0.75

Hepatitis B antigenemia in remote tribes of Northern Kenya, Northern Liberia, and Northern Rhodesia. J Infect Dis (1974) 0.75

Letter: Viral hemorrhagic cystitis. N Engl J Med (1973) 0.75

Serologic response in man to varying amounts of inactivated epidemic typhus vaccine. Proc Soc Exp Biol Med (1967) 0.75

Characterization by hemagglutination-inhibition of adenovirus 11 strains from urine of patients with hemorrhagic cystitis. Proc Soc Exp Biol Med (1973) 0.75

Pneumoccal vaccine: a focus for nursing. Adv Clin Care (1990) 0.75

Development and persistence of antibody to hepatitis-associated (Australia) antigen in patients with hemophilia. J Infect Dis (1971) 0.75

Characteristics and outcome variables of HIV cases at a university-based medical practice. W V Med J (1992) 0.75

Characterization of echovirus types 7, 12, and 29 hemagglutinins for human and monkey erythrocytes. Proc Soc Exp Biol Med (1974) 0.75

Glutaraldehyde for the disinfection of clinical thermometers. Lab Pract (1967) 0.75

Urinary tract infection. Antibacterial susceptibility patterns. Urology (1974) 0.75

Production and characterization of monoclonal antibodies to bovine respiratory syncytial virus. Vet Microbiol (1995) 0.75

Mycoplasma pneumoniae pneumonia. IMJ Ill Med J (1968) 0.75

Development of maduromycosis (Madurella mycetomi) after nailing of a closed tibial fracture: a case report. Clin Orthop Relat Res (1981) 0.75